BRAF-MEK-inhibitor-BRAF-mutant-metastatic-melanoma-NEJM-2014 |
IL-2-Metastatic-Melanoma-JCO-1999 |
Ipilimumab-Metastatic-Melanoma-NEJM-2011 |
Nivolumab-and-ipilimumab-metastatic-melanoma-NEJM-2015 |
Vemurafenib-Metastatic-Melanoma-NEJM-2011 |
Vemurafenib-Refractory-Melanoma-NEJM-2012 |